Preoperative CA 125 Tumour Marker in Endometrial Cancer: Correlation With Advanced Stage Disease

Journal of Obstetrics and Gynaecology Canada

Volumn 32, Issue 9, 2010, Pages 856-860

  Sebastianelli, Alexandra ^a   Renaud, Marie Claude ^a   Grégoire, Jean ^a   Roy, Michel ^a   Plante, Marie ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

CA 125; Endometrial cancer; Prognostic factors; Tumour markers

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

ADULT; ADVANCED CANCER; ARTICLE; ASSAY; BLOOD LEVEL; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; TUMOR INVASION; BLOOD; CARCINOMA; ENDOMETRIUM TUMOR; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE;

CA-125 ANTIGEN; CARCINOMA; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 79952110311     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34657-6     Document Type: Article

References (19)

1. Ben-Shachar I., Pavelka J., Cohn D.E., Copeland L.J., Ramirez N., Manolitsas T., et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 2005, 105:487-493.
2. Chand J.K., WU H., Heung M.K., Shin J.Y., Osann K., Kapp D.S. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 2007, 106:282-288.
3. Cannistra S.A. Cancer of the ovary. N Engl J Med 2004, 351:2519-2529.
4. Dotters D.J., Preoperative C.A. 125 in endometrial cancer: is it useful?. Am J Obstet Gynecol 2000, 182:1328-1334.
5. Sorosky J.I. Endometrial cancer. Obstet Gynecol 2008, 111:436-447.
6. International Federation of Gynecology and Obstetrics (FIGO) Annual report on the results of treatment in gynaecologic cancer. Int J Gynecol Obstet 1989, 28:189-193.
7. Hsieh C.H., Changchien C.C., Lin H., Huang E.Y., Huang C.C., Lan K.C., et al. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?. Gynecol Oncol 2002, 86:28-33.
8. Chung H.H., Kim J.W., Park N.H., Song Y.S., Kang S.B., Lee H.P. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand 2006, 85:1501-1505.
9. Patsner B., Mann W.J., Cohen H., Loesch M. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma. Am J Obstet Gynecol 1988, 158:399-402.
10. Ebina Y., Sakuragi N., Hareyama H., Todo Y., Nomura E., Takeda M., et al. Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma. Acta Obstet Gynecol Scand 2002, 81:458-465.
11. Schneider J., Centeno M., Saez F., Genolla J., Ruibal A. Preoperative CA-125, CA 19-9 and nuclear magnetic resonance in endometrial carcinoma: correlation with surgical stage. Tumour Biol 1999, 20:25-29.
12. Santala M., Talvensaari-Mattila A., Kauppila A. Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicator of overall survival in advanced endometrial cancer. Anticancer Res 2003, 23(3C):3097-3104.
13. Lo S.S., Cheng D.K., Ng T.Y., Wong L.C., Ngan H.Y. Prognostic significance of tumour markers in endometrial cancer. Tumor Biol 1997, 18:241-249.
14. Takac I., Gisek B. Serum CA 125 levels and lymph node metastasis in patien with endometrial cancer. Wien Klin Wochenschr 2006, 118(Suppl 2):62-65.
15. Koper N.P., Massuger L.F., Thomas C.M., Kiemeney L.A., Verbeek A.L. Serum CA 125 measurement to identify patients with endometrial cancer who require lymphadenectomy. Anticancer Res 1998, 18(3B):1897-1902.
16. Lo S.S., Khoo U.S., Cheng D.K., Ng T.Y., Wong L.C., Ngan H.Y. Role of serial tumor markers in the surveillance for recurrence in endometrial cancer. Cancer Detect Prev 1999, 23:397-400.
17. Rose P.G., Sommers R.M., Reale F.R., Hunter R.E., Fournier L., Nelson B.E. Serial serum CA 125 measurement for evaluation of recurrence in patients with endometrial carcinoma. Obstet Gynecol 1994, 84:2-16.
18. Denschlag D., Tan l, Patel S., Kerim-Dikeni A., Souhami L., Gilbert L. Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome. Am J Obstet Gynecol 2007, 546(196):e1-e7.
19. Carlson K.J., Skates S.J., Singer D.E. Screening for ovarian cancer. Ann Intern Med 1994, 121:124-132.